Sequent Scientific has completed acquisition of 15% stake in Fendigo BV through Alivira Animal Health, Ireland, wholly owned subsidiary of the Company. On completion of the said transaction, Fendigo BV has become a Wholly Owned Subsidiary of the Company.
Sequent Scientific is an integrated pharmaceutical company with a global footprint headquartered in Bangalore, India which has presence in different pharmaceutical verticals including APIs, Animal Health, Analytical Services, CRAMS and specialty chemicals. Sequent is the world's largest producer of Anthelmintics and by far the strongest player in the Veterinary API business.
